AAAAAA
Results:
1-24
|
Results: 24
Authors:
MACK R
SAMAAN P
PODOLAK I
ALBANESE E
Citation: R. Mack et al., PREVALENCE OF FACTOR-V-LEIDEN IN AFRICAN-AMERICANS, Research communications in molecular pathology and pharmacology, 99(3), 1998, pp. 339-343
Authors:
WONG SL
CAO G
MACK R
GRANNEMAN GR
Citation: Sl. Wong et al., LACK OF CYP3A INHIBITION EFFECTS OF SERTINDOLE ON TERFENADINE IN HEALTHY-VOLUNTEERS, International journal of clinical pharmacology and therapeutics, 36(3), 1998, pp. 146-151
Authors:
VISWANATHAN S
MOCKUS L
VENKATASUBRAMANIAN V
BASU PK
MACK R
CHERUKAT P
ISKOS V
Citation: S. Viswanathan et al., ITOPS - AN INTELLIGENT TOOL FOR OPERATING PROCEDURES SYNTHESIS, Computers & chemical engineering, 22, 1998, pp. 601-608
Authors:
NICHOLSON JKA
STEIN D
MUI T
MACK R
HUBBARD M
DENNY T
Citation: Jka. Nicholson et al., EVALUATION OF A METHOD FOR COUNTING ABSOLUTE NUMBERS OF CELLS WITH A FLOW CYTOMETER, Clinical and diagnostic laboratory immunology, 4(3), 1997, pp. 309-313
Authors:
ERESHEFSKY L
NABULSI A
SILBER C
MACK R
Citation: L. Ereshefsky et al., REDUCTION OF HOSPITAL DAYS IN SERTINDOLE TREATED PATIENTS - ONE-YEAR FINDINGS, Schizophrenia research, 24(1-2), 1997, pp. 201-202
Authors:
BUCKLEY P
CUTLER N
SILBER C
ONEIL J
MACK R
Citation: P. Buckley et al., THE SAFETY AND TOLERABILITY OF SERTINDOLE IN ELDERLY PATIENTS WITH DEMENTIA, Schizophrenia research, 24(1-2), 1997, pp. 201-201
Authors:
RAMIREZ L
SILBER C
MACK R
Citation: L. Ramirez et al., THE LONG-TERM CARDIOVASCULAR SAFETY OF SERTINDOLE, Schizophrenia research, 24(1-2), 1997, pp. 202-202
Authors:
LAHTI A
SILBER C
MACK R
Citation: A. Lahti et al., THE ACTION OF SERTINDOLE ON NEGATIVE SYMPTOMS IN SCHIZOPHRENIA, Schizophrenia research, 24(1-2), 1997, pp. 202-202
Authors:
GRANNEMAN R
WOZNIAK P
TRANJOHNSON T
SILBER C
MACK R
Citation: R. Granneman et al., POPULATION PHARMACOKINETICS OF SERTINDOLE DURING LONG-TERM TREATMENT OF PATIENTS WITH SCHIZOPHRENIA, Schizophrenia research, 24(1-2), 1997, pp. 202-202
Authors:
SWANN A
HOLGATE K
STASER J
SILBER C
MACK R
Citation: A. Swann et al., A MULTICENTER, ONE-YEAR, HALOPERIDOL CONTROLLED TRIAL ASSESSING THE LONG-TERM SAFETY, EFFICACY AND QUALITY-OF-LIFE OF SERTINDOLE IN STABLE SCHIZOPHRENIC-PATIENTS, Schizophrenia research, 24(1-2), 1997, pp. 203-203
Authors:
SUPPES T
LEE A
PAUL B
SANCHEZ B
MACK R
Citation: T. Suppes et al., THE ATYPICAL ANTIPSYCHOTIC SERTINDOLE - A CASE SERIES, Schizophrenia research, 24(1-2), 1997, pp. 203-203
Authors:
WONG SL
LINNEN P
MACK R
GRANNEMAN GR
Citation: Sl. Wong et al., EFFECTS OF FOOD, ANTACID, AND DOSAGE FORM ON THE PHARMACOKINETICS ANDRELATIVE BIOAVAILABILITY OF SERTINDOLE IN HEALTHY-VOLUNTEERS, Biopharmaceutics & drug disposition, 18(6), 1997, pp. 533-541
Authors:
MACK R
Citation: R. Mack, THE MYSTERY OF THE SCOTTISH GENTLEMAN EMIGRANT FROM 1782 -ZEALAND HISTORY( NEW), Journal of Pacific history, 32(2), 1997, pp. 243-249
Authors:
MACK R
SALMONI A
VIVERAISDRESSLER G
PORTER E
GARG R
Citation: R. Mack et al., PERCEIVED RISKS TO INDEPENDENT LIVING - THE VIEWS OF OLDER, COMMUNITY-DWELLING ADULTS, The Gerontologist, 37(6), 1997, pp. 729-736
Authors:
RAMIREZ L
FOLEY S
DAWSON M
ZYLBERMAN K
MACK R
Citation: L. Ramirez et al., THE LONG-TERM SAFETY OF SERTINDOLE, Biological psychiatry, 41, 1997, pp. 68-68
Authors:
CUNNINGHAM L
HOLGATE K
STASER J
MACK R
Citation: L. Cunningham et al., SERTINDOLE VERSUS HALOPERIDOL - A ONE-YEAR STUDY, Biological psychiatry, 41, 1997, pp. 69-69
Authors:
TAPP A
WOZNIAK P
MACK R
Citation: A. Tapp et al., DIFFERENTIATION BETWEEN DIRECT AND INDIRECT DRUG EFFECTS ON NEGATIVE SYMPTOMS IN SCHIZOPHRENIC-PATIENTS TREATED WITH SERTINDOLE, Biological psychiatry, 41, 1997, pp. 73-73
Authors:
TAMMINGA C
GAO KM
SILBER C
MACK R
Citation: C. Tamminga et al., SERTINDOLE PRODUCES LOW RATES OF RAT ORAL DYSKINESIA WITH CHRONIC ADMINISTRATION, Biological psychiatry, 41, 1997, pp. 144-144
Authors:
SCHULZ SC
MACK R
ZBOROWSKI J
MORRIS D
SEBREE T
WALLIN B
Citation: Sc. Schulz et al., EFFICACY, SAFETY, AND DOSE-RESPONSE OF 3 DOSES OF SERTINDOLE AND 3 DOSES OF HALDOL IN SCHIZOPHRENIC-PATIENTS, Schizophrenia research, 18(2-3), 1996, pp. 6-6
Authors:
POTKIN SG
ZBOROWSKI J
WU J
MACK R
AURANG C
SEBREE T
CARREON D
BERA R
Citation: Sg. Potkin et al., BRAIN IMAGING TO DETERMINE THE EFFECTS OF SERTINDOLE IN SCHIZOPHRENIC-PATIENTS, Psychopharmacology bulletin, 32(3), 1996, pp. 498-498
Authors:
POTKIN S
ZBOROWSKI J
WU J
MACK R
BERA R
SEBREE T
AURANG C
BUNNEY W
Citation: S. Potkin et al., BRAIN IMAGING TO DETERMINE THE EFFECTS OF SERTINDOLE IN SCHIZOPHRENIC-PATIENTS, Biological psychiatry, 39(7), 1996, pp. 52-52
Authors:
BARK N
MACK R
ZBOROWSKI J
MORRIS D
SEBREE T
SHOOK S
WALLIN B
Citation: N. Bark et al., EFFICACY AND SAFETY OF 3 DOSES OF SERTINDOLE AND HALOPERIDOL IN SCHIZOPHRENIC-PATIENTS, Biological psychiatry, 39(7), 1996, pp. 332-332
Authors:
MACK R
Citation: R. Mack, FIBER OPTIC MARKET WILL MORE THAN DOUBLE BY DECADES END, Photonics spectra, 29(1), 1995, pp. 111-112
Authors:
ALY NA
MACK R
Citation: Na. Aly et R. Mack, TQM IMPLEMENTATION IN HOSPITALS, Computers & industrial engineering, 25(1-4), 1993, pp. 299-302
Risultati:
1-24
|